What are ‘true normal’ liver stiffness values using FibroScan®?: a prospective study in healthy living liver and kidney donors in South Korea

Aims: To identify the normal range of liver stiffness (LS) values by recruiting healthy living liver and kidney donors in South Korea.

[1]  C. Corpechot,et al.  Gender and liver: Is the liver stiffness weaker in weaker sex? , 2006, Hepatology.

[2]  M. Brunetto,et al.  Liver stiffness in the hepatitis B virus carrier: a non-invasive marker of liver disease influenced by the pattern of transaminases. , 2008, World journal of gastroenterology.

[3]  F. Brunello,et al.  Is liver stiffness measurement different in patients with NASH or with viral hepatitis , 2008 .

[4]  M. Ziol,et al.  Features associated with success rate and performance of FibroScan measurements for the diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients. , 2007, Journal of hepatology.

[5]  Christos Christidis,et al.  Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C , 2005, Hepatology.

[6]  M. Bia,et al.  The evaluation and selection of living kidney donors. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[7]  M. Campbell,et al.  Noninvasive Assessment of Liver Fibrosis by Measurement of Stiffness in Patients With Chronic Hepatitis C , 2006 .

[8]  Z. Goodman,et al.  Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c. , 2001, Journal of hepatology.

[9]  Pierre Bedossa,et al.  Non‐invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[10]  Dario Conte,et al.  Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease , 2007, Gut.

[11]  Z. Sparchez,et al.  745 THE INFLUENCE OF FATTY LOAD ON LIVER STIFFNESS IN CHRONIC HEPATITIS C PATIENTS , 2008 .

[12]  M. Ziol,et al.  Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC , 2006, Hepatology.

[13]  K. Reddy,et al.  Progression of liver fibrosis in women infected with hepatitis C: Long‐term benefit of estrogen exposure , 2005, Hepatology.

[14]  G. Everson,et al.  Evaluation of 100 patients for living donor liver transplantation , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[15]  M. Ziol,et al.  Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. , 2003, Ultrasound in medicine & biology.

[16]  A. Clouston,et al.  Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis , 1999, Hepatology.

[17]  A. Marcos.  Right lobe living donor liver transplantation: A review , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[18]  Paul Zimmet,et al.  The metabolic syndrome—a new worldwide definition , 2005, The Lancet.

[19]  Y. N. Park,et al.  How Can We Enhance the Performance of Liver Stiffness Measurement Using FibroScan in Diagnosing Liver Cirrhosis in Patients With Chronic Hepatitis B? , 2010, Journal of clinical gastroenterology.

[20]  S. Varnous,et al.  Liver stiffness is an unreliable marker of liver fibrosis in patients with cardiac insufficiency , 2008, Hepatology.

[21]  W. Kannel,et al.  The natural history of congestive heart failure: the Framingham study. , 1971, The New England journal of medicine.

[22]  A. Chan,et al.  Alanine aminotransferase‐based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B , 2009, Journal of viral hepatitis.

[23]  M. Ziol,et al.  87 Prediction of liver fibrosis in non-alcoholic steatohepatitis (NASH): Risk factors and diagnostic potential of liver elasticity using fibroscan , 2006 .

[24]  Robert C. Wolpert,et al.  A Review of the , 1985 .

[25]  I. Sporea,et al.  Transient elastographic evaluation of subjects without known hepatic pathology: does age change the liver stiffness? , 2009, Journal of gastrointestinal and liver diseases : JGLD.

[26]  P. Bedossa,et al.  Natural history of liver fibrosis progression in patients with chronic hepatitis C , 1997, The Lancet.

[27]  I. Shimizu,et al.  Suppressive effects of estradiol on dimethylnitrosamine‐induced fibrosis of the liver in rats , 1999, Hepatology.

[28]  S. Taylor-Robinson,et al.  Liver stiffness values in healthy subjects: implications for clinical practice. , 2008, Journal of hepatology.

[29]  C. Nishida,et al.  Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies , 2004, The Lancet.

[30]  Y. N. Park,et al.  Liver Stiffness Measurement in Combination With Noninvasive Markers for the Improved Diagnosis of B-viral Liver Cirrhosis , 2009, Journal of clinical gastroenterology.

[31]  F. Oberti,et al.  Learning curve and interobserver reproducibility evaluation of liver stiffness measurement by transient elastography: , 2017 .

[32]  A. Nakajima,et al.  Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD) , 2007, Gut.

[33]  Anne-Claire Vergnaud,et al.  Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome. , 2008, Journal of hepatology.

[34]  Y. N. Park,et al.  Usefulness of FibroScan for Detection of Early Compensated Liver Cirrhosis in Chronic Hepatitis B , 2009, Digestive Diseases and Sciences.